Abstracts

915 – Characteristics of Secondary Hemophagocytic Lymphohistiocytosis in People Living With HIV/AIDS

Background Hemophagocytic lymphohistiocytosis (HLH), commonly known as hemophagocytic syndrome, is a rare and serious disease triggered by a myriad of stimuli. HLH is characterized by an uncontrolled cytokine production and persistent lymphocyte and macrophage activation which results in hemophagocytosis. Since people living with human immunodeficiency virus (PLWH) have an increased risk of coinfections, HLH has…

765 – Liver Steatosis Progression With Integrase Inhibitors in HIV Adults in Low-/Middle-Income Countries

Background Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) regimens are widely used and linked to weight gain in some patients, potentially contributing to liver steatosis in people living with HIV (PWH). We assessed predictors of liver steatosis progression over 24 months in PWH from Low-and Middle-Income Countries (LMICs). Methods The Sentinel Research Network (SRN)-IeDEA…

805 – HPV Detection by Vaginal Self-Sampling and Urine Collection in Women Living With HIV: AUTOCol Study

Background Vaginal self-sampling (VSS) has been implemented as the primary cervical cancer screening tool in several countries around the world. Urine collection (UC) can be an alternative if women are uncomfortable with genital sampling. Women living with HIV (WLHIV) are at increased risk of cervical intraepithelial lesions. Methods AUTOCol is a multicentre prospective study enrolling…

789 – Validation of Quantification of Lesional KSHV DNA Content for Diagnosis of Kaposi Sarcoma in Africa

Background Inaccessibility and inaccuracies limit histopathologic diagnosis of Kaposi sarcoma (KS) in Africa. We hypothesized that quantification of KSHV DNA from suspicious skin lesions could distinguish KS from non-KS lesions, thus eventually enabling creation of a diagnostic test that would limit need for histopathologic interpretation. In our earlier training population, quantification of lesional KSHV DNA…

762 – Determinants of Steatotic Liver Disease Among People With HIV in Europe and Australia

Background Given the increased prevalence of steatotic liver disease (SLD) in people with HIV, understanding its natural course and progression to liver fibrosis is crucial for guiding clinical management.  Methods We assessed SLD and liver fibrosis in RESPOND participants from January 2012 to December 2022 using serological scores validated for people with HIV, excluding those with…

753 – Impact of HIV Infection on the Dynamics of Liver Stiffness After HCV Cure

Background During HCV active chronic infection, HIV co-infection promotes liver fibrogenesis and accelerates the progression towards cirrhosis. After sustained virological response (SVR), liver stiffness (LS) usually decreases, regardless of HIV co-infection. However, information related to the impact of HIV co-infection on LS dynamics in this subset is scarce. Methods Multicenter prospective study conducted in the…

763 – Diabetes Mellitus and Liver Disease Progression in PWH With Metabolic Dysfunction-Associated SLD

Background We investigated the risk of liver stiffness progression and advanced liver fibrosis (LF) by diabetes mellitus (DM) status among people with HIV (PWH) and metabolic-dysfunction associated stetotic liver disease (MASLD). Methods PWH who had MASLD at their first vibration-controlled transient elastography or VCTE with both liver stiffness measurement (LSM) and controlled attenuation parameter (CAP)…